Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II

被引:24
|
作者
Yatabe, Junichi [1 ]
Sanada, Hironobu [1 ,3 ,4 ]
Yatabe, Midori Sasaki [1 ]
Hashimoto, Shigeatsu [1 ]
Yoneda, Minoru [2 ]
Felder, Robin A. [2 ]
Jose, Pedro A. [3 ,4 ]
Watanabe, Tsuyoshi [1 ]
机构
[1] Fukushima Med Univ, Dept Internal Med 3, Sch Med, Fukushima 9601295, Japan
[2] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA
[3] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA
[4] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA
关键词
hypertension; PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INVERSE AGONISTS; BLOOD-PRESSURE; SALT INTAKE; EXPRESSION; STRETCH; GENERATION; RENIN;
D O I
10.1152/ajprenal.00580.2007
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T. Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol 296: F1052-F1060, 2009. First published March 4, 2009; doi:10.1152/ajprenal.00580.2007.- It has been reported that mechanical strain activates extracellular signal-regulated protein kinases (ERK) without the involvement of angiotensin II (Ang II) in cardiomyocytes. We examined the effects of mechanical strain on ERK phosphorylation levels in the absence of Ang II using rat mesangial cells. The ratio of phosphorylated ERK (p-ERK) to total ERK expression was increased by cyclic mechanical strain in a time- and elongation strength-dependent manner. With olmesartan [ Ang II type 1 receptor (AT1R) antagonist] pretreatment, p-ERK plateau levels decreased in a dose-dependent manner (EC50 = 1.3 x 10(-8) M, maximal inhibition 50.6 +/- 11.0% at 10(-5) M); a similar effect was observed with RNA interference against Ang II type 1A receptor (AT(1A)R) and Tempol, a superoxide dismutase mimetic. In addition to the inhibition of p-ERK levels, olmesartan blocked the increase in cell surface and phosphorylated p47(phox) induced by mechanical strain and also lowered the mRNA expression levels of NADPH oxidase sub-units. These results demonstrate that mechanical strain stimulates AT1R to phosphorylate ERK in mesangial cells in the absence of Ang II. This mechanotransduction mechanism is involved in the oxidative stress caused by NADPH oxidase and is blocked by olmesartan. The inverse agonistic activity of this AT1R blocker may be useful for the prevention of mesangial proliferation and renal damage caused by mechanical strain/oxidative stress regardless of circulating or tissue Ang II levels.
引用
收藏
页码:F1052 / F1060
页数:9
相关论文
共 50 条
  • [1] Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4
    Fazeli, Gholamreza
    Stopper, Helga
    Schinzel, Reinhard
    Ni, Chih-Wen
    Jo, Hanjoong
    Schupp, Nicole
    MUTAGENESIS, 2012, 27 (06) : 673 - 681
  • [2] Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner
    Ishizawa, Keisuke
    Izawa-Ishizawa, Yuki
    Dorjsuren, Narantungalag
    Miki, Erika
    Kihira, Yoshitaka
    Ikeda, Yasumasa
    Hamano, Shuichi
    Kawazoe, Kazuyoshi
    Minakuchi, Kazuo
    Tomita, Shuhei
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (02) : 364 - 372
  • [3] Effects of Combined Treatment with Angiotensin II Type 1 Receptor Blocker and Statin on Stent Restenosis
    Yoshikawa, Masaki
    Nakamura, Kazufumi
    Nagase, Satoshi
    Sakuragi, Satoru
    Kusano, Kengo F.
    Matsubara, Hiromi
    Ohe, Tohru
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (02) : 179 - U2
  • [4] "Angiotensin II memory" contributes to the development of hypertension and vascular injury via activation of NADPH oxidase
    Li, Wen-Jun
    Liu, Ying
    Wang, Jing-Jing
    Zhang, Yun-Long
    Lai, Song
    Xia, Yun-Long
    Wang, Hong-Xia
    Li, Hui-Hua
    LIFE SCIENCES, 2016, 149 : 18 - 24
  • [5] Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling
    Kato, Takeshi
    Yamashita, Takeshi
    Sekiguchi, Akiko
    Tsuneda, Takayuki
    Sagara, Kouichi
    Takamura, Masayuki
    Kaneko, Shuichi
    Aizawa, Tadanori
    Fu, Long-Tai
    JOURNAL OF CARDIOLOGY, 2011, 58 (02) : 131 - 136
  • [6] Dieckol Reduces Muscle Atrophy by Modulating Angiotensin Type II Type 1 Receptor and NADPH Oxidase in Spontaneously Hypertensive Rats
    Oh, Seyeon
    Yang, Jin Young
    Park, Chul Hyun
    Son, Kuk Hui
    Byun, Kyunghee
    ANTIOXIDANTS, 2021, 10 (10)
  • [7] Angiotensin II and NADPH Oxidase Increase ADMA in Vascular Smooth Muscle Cells
    Luo, Zaiming
    Teerlink, Tom
    Griendling, Kathy
    Aslam, Shakil
    Welch, William J.
    Wilcox, Christopher S.
    HYPERTENSION, 2010, 56 (03) : 498 - U337
  • [8] Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism
    Habashi, Jennifer P.
    Doyle, Jefferson J.
    Holm, Tammy M.
    Aziz, Hamza
    Schoenhoff, Florian
    Bedja, Djahida
    Chen, YiChun
    Modiri, Alexandra N.
    Judge, Daniel P.
    Dietz, Harry C.
    SCIENCE, 2011, 332 (6027) : 361 - 365
  • [9] Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model
    Armstrong, Zachary B.
    Boughner, Derek R.
    Drangova, Maria
    Rogers, Kem A.
    CARDIOVASCULAR RESEARCH, 2011, 90 (01) : 165 - 170
  • [10] Angiotensin II type 1 receptor blocker attenuates myocardial remodeling and preserves diastolic function in diabetic heart
    Tsutsui, Hiroyuki
    Matsushima, Shouji
    Kinugawa, Shintaro
    Ide, Tomomi
    Inoue, Naoki
    Ohta, Yukihiro
    Yokota, Takashi
    Hamaguchi, Sanae
    Sunagawa, Kenji
    HYPERTENSION RESEARCH, 2007, 30 (05) : 439 - 449